Rhumbline Advisers Mirum Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 55,434 shares of MIRM stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,434
Previous 53,113
4.37%
Holding current value
$2.19 Million
Previous $2.2 Million
16.07%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MIRM
# of Institutions
213Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$259 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$181 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$128 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$110 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$103 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.45B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...